$506 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 32 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 62.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $244,420,000 | -14.5% | 2,061,402 | -0.7% | 48.33% | +18.9% |
| QDEL | Sell | QUIDEL CORP | $79,693,000 | -31.0% | 708,631 | -17.1% | 15.76% | -3.9% |
| OPK | Sell | OPKO HEALTH INC | $30,911,000 | -47.4% | 8,985,756 | -26.5% | 6.11% | -26.8% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $27,979,000 | +20.9% | 1,720,733 | +3.0% | 5.53% | +68.3% |
| AGEN | Sell | AGENUS INC | $21,417,000 | -27.0% | 8,706,132 | -4.4% | 4.24% | +1.6% |
| ARKK | New | ARK ETF TRinnovation etf | $16,573,000 | – | 250,000 | +100.0% | 3.28% | – |
| New | SEMA4 HOLDINGS CORP | $12,111,000 | – | 3,944,832 | +100.0% | 2.40% | – | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $11,151,000 | -61.7% | 1,225,395 | -13.7% | 2.20% | -46.7% |
| Buy | DERMTECH INC | $9,585,000 | +0.6% | 652,907 | +8.3% | 1.90% | +40.0% | |
| FORA | Buy | FORIAN INC | $8,784,000 | -20.2% | 1,262,040 | +3.5% | 1.74% | +11.1% |
| CFRX | Buy | CONTRAFECT CORP | $7,133,000 | +38.9% | 1,954,222 | +0.1% | 1.41% | +93.2% |
| ATRS | ANTARES PHARMA INC | $7,052,000 | +14.9% | 1,720,000 | 0.0% | 1.39% | +59.9% | |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $4,524,000 | – | 186,789 | +100.0% | 0.90% | – |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $3,934,000 | -79.2% | 2,731,856 | -24.7% | 0.78% | -71.1% |
| CDAK | Sell | CODIAK BIOSCIENCES INC | $3,164,000 | -56.9% | 504,602 | -23.5% | 0.63% | -40.0% |
| IMMP | IMMUTEP LTDsponsored ads | $2,675,000 | -16.5% | 976,156 | 0.0% | 0.53% | +16.3% | |
| IBRX | New | IMMUNITYBIO INC | $2,244,000 | – | 400,013 | +100.0% | 0.44% | – |
| AWH | Sell | ASPIRA WOMENS HEALTH INC | $2,202,000 | -77.6% | 2,116,839 | -61.8% | 0.44% | -68.8% |
| LABU | New | DIREXION SHS ETF TRput | $1,775,000 | – | 1,000,000 | +100.0% | 0.35% | – |
| CNC | Sell | CENTENE CORP DELput | $1,485,000 | +179.7% | 300,000 | -27.9% | 0.29% | +292.0% |
| PFE | Sell | PFIZER INCput | $1,265,000 | -91.6% | 550,000 | -60.7% | 0.25% | -88.3% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INCput | $1,263,000 | -8.7% | 550,000 | -21.4% | 0.25% | +26.9% |
| ACAD | New | ACADIA PHARMACEUTICALS INCput | $1,058,000 | – | 459,300 | +100.0% | 0.21% | – |
| Sell | DERMTECH INCput | $921,000 | +116.7% | 193,800 | -22.5% | 0.18% | +203.3% | |
| VTNR | New | VERTEX ENERGY INC | $547,000 | – | 55,000 | +100.0% | 0.11% | – |
| BIIB | BIOGEN INC | $508,000 | -12.3% | 2,412 | 0.0% | 0.10% | +22.0% | |
| SLNO | SOLENO THERAPEUTICS INC | $475,000 | -45.7% | 2,132,000 | 0.0% | 0.09% | -24.2% | |
| OPK | Sell | OPKO HEALTH INCput | $292,000 | -57.4% | 749,900 | -1.0% | 0.06% | -40.2% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lput | $212,000 | – | 20,000 | +100.0% | 0.04% | – |
| QDEL | New | QUIDEL CORPput | $200,000 | – | 26,500 | +100.0% | 0.04% | – |
| ABUS | New | ARBUTUS BIOPHARMA CORP | $149,000 | – | 50,000 | +100.0% | 0.03% | – |
| PTIX | Sell | PROTAGENIC THERAPEUTICS INC | $16,000 | -96.2% | 20,000 | -93.3% | 0.00% | -94.9% |
| AGEN | Exit | AGENUS INCput | $0 | – | -298,300 | -100.0% | -0.00% | – |
| MOTS | Exit | MOTUS GI HLDGS INC | $0 | – | -105,885 | -100.0% | -0.01% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF INput | $0 | – | -67,000 | -100.0% | -0.02% | – |
| XBIT | Exit | XBIOTECH INCput | $0 | – | -500,000 | -100.0% | -0.10% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -350,000 | -100.0% | -0.15% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -500,000 | -100.0% | -0.19% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INCput | $0 | – | -287,600 | -100.0% | -0.22% | – |
| CCRN | Exit | CROSS CTRY HEALTHCARE INC | $0 | – | -71,000 | -100.0% | -0.28% | – |
| PFE | Exit | PFIZER INC | $0 | – | -475,000 | -100.0% | -3.99% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -861,008 | -100.0% | -5.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.